Search
Gaurang Telang is a translational immunology researcher working at the intersection of CAR-T cell engineering, T-cell functional profiling, and GMP-aligned translational workflows at the Leibniz Institute for Immunotherapy (LIT) in Regensburg, Germany.
His day-to-day work is bench-intensive and process-driven, focused on engineering, measuring, and validating T-cell products with an emphasis on reproducibility, documentation, and clinical translation. He works in a pre-GMP translational environment that bridges basic immunology research with downstream clinical and manufacturing requirements.
Gaurang completed his schooling, undergraduate education (BTech in Biotechnology), and postgraduate training (MSc Biotechnology) in India, with academic and professional experience across Mumbai and Pune. His early career included hands-on work in startups and industry laboratories, where he helped establish biologics workflows, quality control assays, and cellular bench processes during the COVID period.
This industry exposure proved formative. While his academic training built strong fundamentals, it was industry-based troubleshooting, assay development, and workflow ownership that shaped his translational mindset.
He is currently completing his PhD in India, focused on antigen-specific T-cell responses in cancer, while simultaneously working in Germany, an unconventional but deliberate path that allowed him to combine deep bench skill development with real-world translational exposure.
At LIT, Gaurang works within a dedicated translational T-cell group connected directly to clinical and GMP ecosystems. His research focuses on:
Rather than purely exploratory research, his work is intentionally aligned with clinical translation, where many therapies fail not because of weak biology, but because of poor process discipline.